Most Recent Funding
$1.6 Million Grant on November 15, 2013
Founded:
2002
Headquarters:
Monmouth Junction, NJ
Description:
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Categories:
Biotechnology
Website:
http://www.signumbiosciences.com

Detailed Description

Update

Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for several skin conditions, Alzheimer's, Parkinson's, asthma and COPD. Signum’s STM technology provides many opportunities for the development of novel consumer products and pharmaceutical candidates.

Current Team (2)

Update

Funding Rounds (2) - $1.6M

Update

Offices/Locations (1)

Update
  • Office

    7 Deer Park Drive

    Suite H

    Monmouth Junction, NJ 08852

    USA